Literature DB >> 24522918

Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Tawin Iempridee1, Jessica A Reusch, Andrew Riching, Eric C Johannsen, Sinisa Dovat, Shannon C Kenney, Janet E Mertz.   

Abstract

UNLABELLED: Ikaros is a zinc finger DNA-binding protein that regulates chromatin remodeling and the expression of genes involved in the cell cycle, apoptosis, and Notch signaling. It is a master regulator of lymphocyte differentiation and functions as a tumor suppressor in acute lymphoblastic leukemia. Nevertheless, no previous reports described effects of Ikaros on the life cycle of any human lymphotropic virus. Here, we demonstrate that full-length Ikaros (IK-1) functions as a major factor in the maintenance of viral latency in Epstein-Barr virus (EBV)-positive Burkitt's lymphoma Sal and MutuI cell lines. Either silencing of Ikaros expression by small hairpin RNA (shRNA) knockdown or ectopic expression of a non-DNA-binding isoform induced lytic gene expression. These effects synergized with other lytic inducers of EBV, including transforming growth factor β (TGF-β) and the hypoxia mimic desferrioxamine. Data from chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR) and ChIP-sequencing (ChIP-seq) analyses indicated that Ikaros did not bind to either of the EBV immediate early genes BZLF1 and BRLF1. Rather, Ikaros affected the expression of Oct-2 and Bcl-6, other transcription factors that directly inhibit EBV reactivation and plasma cell differentiation, respectively. IK-1 also complexed with the EBV immediate early R protein in coimmunoprecipitation assays and partially colocalized with R within cells. The presence of R alleviated IK-1-mediated transcriptional repression, with IK-1 then cooperating with Z and R to enhance lytic gene expression. Thus, we conclude that Ikaros plays distinct roles at different stages of EBV's life cycle: it contributes to maintaining latency via indirect mechanisms, and it may also synergize with Z and R to enhance lytic replication through direct association with R and/or R-induced alterations in Ikaros' functional activities via cellular signaling pathways. IMPORTANCE: This is the first report showing that the cellular protein Ikaros, a known master regulator of hematopoiesis and critical tumor suppressor in acute lymphoblastic leukemia, also plays important roles in the life cycle of Epstein-Barr virus in B cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522918      PMCID: PMC3993812          DOI: 10.1128/JVI.03706-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 2.  Ikaros in immune receptor signaling, lymphocyte differentiation, and function.

Authors:  Matthias Merkenschlager
Journal:  FEBS Lett       Date:  2010-10-02       Impact factor: 4.124

3.  Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation.

Authors:  Jukka Alinikula; Kalle-Pekka Nera; Sini Junttila; Olli Lassila
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

4.  Genome-wide analysis of Epstein-Barr virus Rta DNA binding.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Daniel Portal; Yong Lu; Eric Johannsen
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.

Authors:  J Chodosh; V P Holder; Y J Gan; A Belgaumi; J Sample; J W Sixbey
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

6.  Ikaros isoforms: The saga continues.

Authors:  Zhanjun Li; Laura A Perez-Casellas; Aleksandar Savic; Chunhua Song; Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

7.  Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms.

Authors:  Tapani Ronni; Kimberly J Payne; Sam Ho; Michelle N Bradley; Glenn Dorsam; Sinisa Dovat
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

8.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

9.  Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Authors:  Fatih M Uckun; Hong Ma; Jian Zhang; Zahide Ozer; Sinisa Dovat; Cheney Mao; Rita Ishkhanian; Patricia Goodman; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.

Authors:  Hong Ma; Sanjive Qazi; Zahide Ozer; Jian Zhang; Rita Ishkhanian; Fatih M Uckun
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  9 in total

1.  Long non-coding RNA H19 enhances cell proliferation and anchorage-independent growth of cervical cancer cell lines.

Authors:  Tawin Iempridee
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

2.  Infection as a cause of childhood leukemia: virus detection employing whole genome sequencing.

Authors:  Christoph Bartenhagen; Ute Fischer; Klaus Korn; Stefan M Pfister; Michael Gombert; Cai Chen; Vera Okpanyi; Julia Hauer; Anna Rinaldi; Jean-Pierre Bourquin; Cornelia Eckert; Jianda Hu; Armin Ensser; Martin Dugas; Arndt Borkhardt
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941

3.  MYC Controls the Epstein-Barr Virus Lytic Switch.

Authors:  Rui Guo; Chang Jiang; Yuchen Zhang; Apurva Govande; Stephen J Trudeau; Fang Chen; Christopher J Fry; Rishi Puri; Emma Wolinsky; Molly Schineller; Thomas C Frost; Makda Gebre; Bo Zhao; Lisa Giulino-Roth; John G Doench; Mingxiang Teng; Benjamin E Gewurz
Journal:  Mol Cell       Date:  2020-04-20       Impact factor: 17.970

4.  Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.

Authors:  Richard J Jones; Tawin Iempridee; Xiaobin Wang; Hans C Lee; Janet E Mertz; Shannon C Kenney; Heather C Lin; Veerabhadran Baladandayuthapani; Christopher W Dawson; Jatin J Shah; Donna M Weber; Robert Z Orlowski
Journal:  Clin Cancer Res       Date:  2016-06-13       Impact factor: 12.531

Review 5.  Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

Authors:  Thomas C Frost; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2018-09-15       Impact factor: 7.090

6.  Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.

Authors:  S Giunco; A Celeghin; K Gianesin; R Dolcetti; S Indraccolo; A De Rossi
Journal:  Cell Death Dis       Date:  2015-05-28       Impact factor: 8.469

Review 7.  Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.

Authors:  Hongde Li; Sufang Liu; Jianmin Hu; Xiangjian Luo; Namei Li; Ann M Bode; Ya Cao
Journal:  Int J Biol Sci       Date:  2016-10-18       Impact factor: 6.580

8.  Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.

Authors:  Dong-Wen Lv; Kun Zhang; Renfeng Li
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

9.  Identification and Validation of Ikaros (IKZF1) as a Cancer Driver Gene for Marek's Disease Virus-Induced Lymphomas.

Authors:  Alec Steep; Evin Hildebrandt; Hongen Xu; Cari Hearn; Dmitrij Frishman; Masahiro Niikura; John R Dunn; Taejoong Kim; Steven J Conrad; William M Muir; Hans H Cheng
Journal:  Microorganisms       Date:  2022-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.